The Analysis of Factors Affecting Medication Adherence in Patients with Myasthenia Gravis: a Cross-sectional Study

Overview

Journal Ther Adv Neurol Disord

Specialty Neurology

Date 2024 Apr 24

PMID 38654744

Authors

Yining Su

Xinxian Wang

Yuemeng Xing

Zhenni Wang

Hailing Bu

Xiaoyan Cui

Yunying Yang

Bingxing Cai

Affiliations

Soon will be listed here.

Abstract

Background: Clinically, patients with myasthenia gravis are generally treated with drugs to improve their physical condition, and poor medication adherence can hinder their recovery. Many studies have shown the importance of medication adherence for effective treatment. Various factors may affect a patient's medication adherence; however, studies concerning medication adherence in patients with myasthenia gravis are rare.

Objectives: This study aimed to identify the factors related to medication adherence in patients with myasthenia gravis, and determine the possibility of predicting medication adherence.

Methods: This cross-sectional observational study was conducted among inpatients and outpatients with myasthenia gravis of the First Affiliated Hospital of Guangzhou University of Chinese Medicine in China. Data on patient demographics, disease-related characteristics, and medical treatment were collected. We evaluated medication adherence of the patients using the Morisky Medication Adherence Scale-8, Beliefs about Medicines Questionnaire, and the Self-efficacy for Appropriate Medication Use Scale.

Results: We distributed 200 questionnaires and finally retrieved 198 valid questionnaires. A total of 139 (70.2%) women participated in this study, and 81 (40.9%) among the 198 participants were aged 40-59 years. In total, 103 (52.0%) participants exhibited bad adherence to pharmacological treatment, and factors such as taking medication irregularly [odds ratio (OR) = 0.242, 95% CI = 0.093-0.627], the necessity of taking medicine (OR = 1.286, 95% CI = 1.142-1.449), the concerns of taking medicine (OR = 0.890, 95% CI = 0.801-0.988), and the self-efficacy for taking medications under difficult circumstances (OR = 1.194, 95% CI = 1.026-1.389) had statistically significant impacts on medication adherence.

Conclusion: Our study shows that taking medication irregularly and concerns of taking medicine are the risk factors for medication adherence. Meanwhile, the necessity of talking medicine and self-efficacy for taking medications under difficult circumstances are the protective factors for medication adherence. Our findings can help medical staff to enhance patients' medication adherence by informing patients necessary medical knowledge, emphasizing the necessity for medication, relieving patients' concerns regarding medication, and improving the self-efficacy for taking medications under difficult circumstances.

References

Arkan G, Ordin Y, Ozturk V, Ala R . Investigation of Medication Adherence and Factors Affecting It in Patients With Stroke. J Neurosci Nurs. 2021; 54(1):35-41. DOI: 10.1097/JNN.0000000000000621. View

Jaam M, Ibrahim M, Kheir N, Awaisu A . Factors associated with medication adherence among patients with diabetes in the Middle East and North Africa region: A systematic mixed studies review. Diabetes Res Clin Pract. 2017; 129:1-15. DOI: 10.1016/j.diabres.2017.04.015. View

Kardas P, Lewek P, Matyjaszczyk M . Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013; 4:91. PMC: 3722478. DOI: 10.3389/fphar.2013.00091. View

Dalakas M . Progress in the therapy of myasthenia gravis: getting closer to effective targeted immunotherapies. Curr Opin Neurol. 2020; 33(5):545-552. DOI: 10.1097/WCO.0000000000000858. View

Pasma A, Vant Spijker A, Hazes J, Busschbach J, Luime J . Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic review. Semin Arthritis Rheum. 2013; 43(1):18-28. DOI: 10.1016/j.semarthrit.2012.12.001. View

Oosterom-Calo R, van Ballegooijen A, Terwee C, Te Velde S, Brouwer I, Jaarsma T . Determinants of adherence to heart failure medication: a systematic literature review. Heart Fail Rev. 2012; 18(4):409-27. PMC: 3677977. DOI: 10.1007/s10741-012-9321-3. View

Nagappa M, Mahadevan A, Gangadhar Y, Patil S, Bokolia S, Bindu P . Autoantibodies in acquired myasthenia gravis: Clinical phenotype and immunological correlation. Acta Neurol Scand. 2019; 139(5):428-437. DOI: 10.1111/ane.13071. View

Osterberg L, Blaschke T . Adherence to medication. N Engl J Med. 2005; 353(5):487-97. DOI: 10.1056/NEJMra050100. View

Daley D, Myint P, Gray R, Deane K . Systematic review on factors associated with medication non-adherence in Parkinson's disease. Parkinsonism Relat Disord. 2012; 18(10):1053-61. DOI: 10.1016/j.parkreldis.2012.09.004. View

10.

Gast A, Mathes T . Medication adherence influencing factors-an (updated) overview of systematic reviews. Syst Rev. 2019; 8(1):112. PMC: 6511120. DOI: 10.1186/s13643-019-1014-8. View

11.

Blum S, Lee D, Gillis D, McEniery D, Reddel S, McCombe P . Clinical features and impact of myasthenia gravis disease in Australian patients. J Clin Neurosci. 2015; 22(7):1164-9. DOI: 10.1016/j.jocn.2015.01.022. View

12.

Carr A, Cardwell C, McCarron P, McConville J . A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010; 10:46. PMC: 2905354. DOI: 10.1186/1471-2377-10-46. View

13.

Mathes T, Pieper D, Antoine S, Eikermann M . Adherence influencing factors in patients taking oral anticancer agents: a systematic review. Cancer Epidemiol. 2014; 38(3):214-26. DOI: 10.1016/j.canep.2014.03.012. View

14.

Verbrugghe M, Verhaeghe S, Lauwaert K, Beeckman D, Van Hecke A . Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treat Rev. 2013; 39(6):610-21. DOI: 10.1016/j.ctrv.2012.12.014. View

15.

Iskandarsyah A, de Klerk C, Suardi D, Soemitro M, Sadarjoen S, Passchier J . Psychosocial and cultural reasons for delay in seeking help and nonadherence to treatment in Indonesian women with breast cancer: a qualitative study. Health Psychol. 2013; 33(3):214-21. DOI: 10.1037/a0031060. View

16.

Ab Rahman N, Lim M, Thevendran S, Ahmad Hamdi N, Sivasampu S . Medication Regimen Complexity and Medication Burden Among Patients With Type 2 Diabetes Mellitus: A Retrospective Analysis. Front Pharmacol. 2022; 13:808190. PMC: 8978326. DOI: 10.3389/fphar.2022.808190. View

17.

Marshall V, Given B . Factors Associated With Medication Beliefs in Patients With Cancer: An Integrative Review. Oncol Nurs Forum. 2018; 45(4):508-526. DOI: 10.1188/18.ONF.508-526. View

18.

Nagane Y, Murai H, Imai T, Yamamoto D, Tsuda E, Minami N . Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study. BMJ Open. 2017; 7(2):e013278. PMC: 5337722. DOI: 10.1136/bmjopen-2016-013278. View

19.

Neter E, Glass-Marmor L, Wolkowitz A, Lavi I, Miller A . Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosis. BMC Neurol. 2021; 21(1):136. PMC: 7992850. DOI: 10.1186/s12883-021-02149-0. View

20.

Kim N, Look K, Dague L, Winn A . Financial burden and medication adherence among near-poor older adults in a pharmaceutical assistance program. Res Social Adm Pharm. 2021; 18(3):2517-2523. DOI: 10.1016/j.sapharm.2021.04.016. View